ReviewFrontiers in bioengineering and biotechnology2026
pH-responsive nanozymes: multifunctional platforms for biomedical catalysis toward clinical translation.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Cold to Hot: Nanozyme-Based Strategies for Reprogramming the Tumour Immunoenvironment.Cell proliferation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As an emerging class of smart nanomaterials, pH-responsive nanozymes are capable of realizing dynamic regulation of catalytic activity according to microenvironmental acidity and alkalinity. The material system encompasses noble metals, metal oxides, metal sulfides, carbon-based nanozymes, and metal-organic frameworks. Through engineering strategies such as surface ligand modification, heterogeneous atom doping and core-shell structure design, these nanozymes can achieve precise response to complex biological microenvironments, and show unique catalytic properties in the lesion site with specific pH. In recent years, pH-responsive nanozymes have been applied in various biomedical fields, such as tumor therapy, antimicrobial, wound healing, and anti-inflammation, to enhance therapeutic efficacy through controlled activation and targeted drug delivery. However, they still face many challenges in clinical translation, such as
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.